Cargando…

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8(+) T Cells

Many tumor-associated antigens are derived from nonmutated “self” proteins. T cells infiltrating tumor deposits recognize self-antigens presented by tumor cells and can be expanded in vivo with vaccination. These T cells exist in a functionally tolerant state, as they rarely result in tumor eradicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Overwijk, Willem W., Theoret, Marc R., Finkelstein, Steven E., Surman, Deborah R., de Jong, Laurina A., Vyth-Dreese, Florry A., Dellemijn, Trees A., Antony, Paul A., Spiess, Paul J., Palmer, Douglas C., Heimann, David M., Klebanoff, Christopher A., Yu, Zhiya, Hwang, Leroy N., Feigenbaum, Lionel, Kruisbeek, Ada M., Rosenberg, Steven A., Restifo, Nicholas P.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2003
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194177/ https://www.ncbi.nlm.nih.gov/pubmed/12925674 http://dx.doi.org/10.1084/jem.20030590

Ejemplares similares

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8(+) T cells
por: Gattinoni, Luca, et al.
Publicado: (2005)

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.
por: Vlasveld, L. T., et al.
Publicado: (1993)

Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
por: Tran, Eric, et al.
Publicado: (2013)

Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models
por: Zhang, Ling, et al.
Publicado: (2020)

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.
por: Vlasveld, L. T., et al.
Publicado: (1992)

gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand
por: Overwijk, Willem W., et al.
Publicado: (1998)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Interferes with Extracellular Signal-regulated Kinase (ERK) and Jun NH(2)-terminal Kinase (JNK) Activation, but Does Not Affect Phosphorylation of T Cell Receptor ζ and ZAP70
por: Calvo, Concepcion Revilla, et al.
Publicado: (1997)

Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2022)

Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits CD8(+) T cell memory formation
por: Ji, Yun, et al.
Publicado: (2011)

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma
por: de Gast, G C, et al.
Publicado: (2003)

Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
por: Overwijk, Willem W, et al.
Publicado: (2013)

Expression of the SNARE Protein SNAP-23 Is Essential for Cell Survival
por: Kaul, Sunil, et al.
Publicado: (2015)

Selective Expansion of Cross-Reactive Cd8(+) Memory T Cells by Viral Variants
por: Haanen, John B.A.G., et al.
Publicado: (1999)

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma
por: Verra, N, et al.
Publicado: (2003)

Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells
por: Church, Sarah E, et al.
Publicado: (2014)

NK cells protect TCR-transgenic mice from developing fetal leukemia
por: Dubois, Sigrid, et al.
Publicado: (2014)

Leukemia/lymphoma development in IL-15-deficient TCR-transgenic mice
por: Dubois, Sigrid, et al.
Publicado: (2015)

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
por: Krogsgaard, Michelle, et al.
Publicado: (2013)

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
por: Murakami, Takashi, et al.
Publicado: (2003)

Pim1 Reconstitutes Thymus Cellularity in Interleukin 7–And Common γ Chain–Mutant Mice and Permits Thymocyte Maturation in Rag- but Not Cd3γ-Deficient Mice
por: Jacobs, Heinz, et al.
Publicado: (1999)

Are the IL-2 Receptors Expressed in the Murine Fetal Thymus Functional?
por: Zoúñiga-Pflücker, Juan Carlos, et al.
Publicado: (1990)

Fas expression in memory CD8+ T cell subsets augments cellular differentiation and effector function
por: Yamamoto, Tori, et al.
Publicado: (2015)

Elevated potassium levels suppress T cell activation within tumors
por: Eil, Robert L, et al.
Publicado: (2015)

Contributions of the T Cell Receptor–associated CD3γ–ITAM to Thymocyte Selection
por: Haks, Mariëlle C., et al.
Publicado: (2002)

Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation
por: Jenkinson, S. Rhiannon, et al.
Publicado: (2007)

Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma
por: Beane, Joal D, et al.
Publicado: (2014)

Induction of an acute vitamin A-deficient state following total body irradiation impairs anti-tumor immunity by altering the homeostasis of pre-cDC derived dendritic cells
por: Klebanoff, Christopher A, et al.
Publicado: (2013)

Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study
por: de Gruijl, Tanja, et al.
Publicado: (2013)

Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen: Implications for Tumor Immunotherapy
por: Colella, Teresa A., et al.
Publicado: (2000)

Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine: Comparison of Prophylaxis and Therapy
por: van Elsas, Andrea, et al.
Publicado: (2001)

Ionic immune suppression within the tumour microenvironment limits T cell effector function
por: Eil, Robert, et al.
Publicado: (2016)

Trade-offs in motivating volunteer effort: Experimental evidence on voluntary contributions to science
por: Lyons, Elizabeth, et al.
Publicado: (2019)

Modulating immunometabolism of tumor specific mouse and human lymphocytes to enhance T cell based therapy for cancer
por: Sukumar, Madhusudhanan, et al.
Publicado: (2015)

Cish actively silences tcr signaling in CD8+ T cells to maintain tumor tolerance
por: Palmer, Douglas, et al.
Publicado: (2015)

Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo
por: Daniel, Jeremy A., et al.
Publicado: (2008)

Constitutive expression of human keratin 14 gene in mouse lung induces premalignant lesions and squamous differentiation
por: Habib Dakir, EL, et al.
Publicado: (2008)

Signal sequence insufficiency contributes to neurodegeneration caused by transmembrane prion protein
por: Rane, Neena S., et al.
Publicado: (2010)

Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014)

A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers
por: Lu, Yong-Chen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k0k0c353h3o03oe86v18ph1414